منابع مشابه
Institute for Research on Poverty Special Report Series Background and Context for the Forum Series
A new series offorums for Congressional staff cosponsored by the
متن کاملSpecial RepoRt
As we know from the literature [1], infections are the second leading cause of death in systemic lupus erythematosus (SLE) patients (25%), immediately after the complications related to disease activity (26%). Infections are an important cause of hospitalization too, mostly if there are some concomitant conditions, such as an active disease with a high SLE disease activity index score, extensiv...
متن کاملSpecial RepoRt
The 3rd European Science Foundation– University of Barcelona (ESF–UB) Conference in Biomedicine on Pharmacogenetics and Pharmacogenomics was held in Sant Feliu de Guixols, Spain, from 6–10 June 2010. It was focused on practical applications in routine medical practice [101]. When planning this conference 2 years ago, we thought it would be interesting to synthesize some knowledge gained in the ...
متن کاملSpecial RepoRt
S290 (2000). 41 Goronzy JJ, Fujii H, Weyand CM. Telomeres, immune aging and autoimmunity. Exp. Gerontol. 41(3), 246–251 (2006). n Presents important findings related to aging and how age influences autoimmunity. 42 Schonland SO, Lopez C, Widmann T et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc. Natl A...
متن کاملSpecial RepoRt
Coumarin derivatives, such as warfarin, acenocoumarol and phenprocoumon, are commonly prescribed as oral anticoagulants for the treatment of thromboembolic disorders. Therapy with coumarin derivatives is most effective when the international normalized ratio (INR) is kept within a narrow range. Prescribing of these drugs is difficult because of their narrow therapeutic window and the wide inter...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Journal of Optometry
سال: 2019
ISSN: 0045-5075
DOI: 10.15353/cjo.73.583